Company Name: Intellia Therapeutics, Inc.      

Intellia Therapeutics, Inc. is a gene editing company. The company is engaged in the development of therapeutics using CRISPR/Cas9 technology.

Ticker Symbol: NTLA (NASDAQ)

Company Website: www.intelliatx.com

Company Profile:

Social Media:

Intellia Therapeutics LinkedIn

Intellia Therapeutics Twitter

Headquarters: Cambridge, Massachusetts